Attorney General Josh Kaul expressed his thoughts on the recent decision made by the Wisconsin Supreme Court to accept jurisdiction in the case Evers v. Marklein. In a statement released today, he emphasized the importance of the separation of powers in the government system."The separation of powers is foundational to our system of government," Attorney General Kaul stated. "That principle, which guards against the concentration of governmental power, is inconsistent with permitting legislative committees to exercise a veto over executive branch actions like DNR's.
Dept of Justice: Attorney General Josh Kaul takes action to protect medication abortion access
wispolitics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wispolitics.com Daily Mail and Mail on Sunday newspapers.
Attorney General Josh Kaul Takes Action to Protect Medication Abortion Access
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Attorney General Josh Kaul has revealed a significant $350 million national settlement with Publicis Health, a global marketing and communications firm, regarding its involvement in the prescription opioid crisis. As part of the agreement, Wisconsin will receive over $6 million from the settlement to aid in addressing the ongoing opioid crisis.Publicis Health has acknowledged the harm caused by its actions, and this settlement will provide additional financial support to communities severely impacted by the opioid crisis. The funds will be utilized for treatment and.
Attorney General Josh Kaul has taken action to protect access to medication abortion by joining a coalition of 24 attorneys general. The coalition has filed an amicus brief in the U.S. Supreme Court to support efforts by the U.S. Food and Drug Administration (FDA) and Danco Laboratories LLC to reverse a ruling by the U.S. Court of Appeals for the Fifth Circuit.The ruling in question reinstated certain restrictions on the medication known as mifepristone, despite the FDA determining that these restrictions were medically unnecessary. Mifepristone, when used in combination.